Macy-Pan
Widest product range of any manufacturer — from ultra-budget soft-shell ($1,300 FOB) to wheelchair-accessible and clinical hard-shell 2.0 ATA units. Strong value for money at every tier.
NOT CLEARED
No FDA clearance, registration, or CE marking found.
Key facts at a glance.
- Founded
- 2009
- Headquarters
- Shanghai, China
- Price range
- $2,500–$5,000
The real price over three years.
Total cost of ownership · 3yr
| Hardwareone-time | $2,500 |
| 3-year total | $2,500 |
What the device does.
- + Widest product range: 13+ configurations (lying, sitting, wheelchair roll-in, hard-shell)
- + Soft-shell models: 1.3-1.5 ATA; Hard-shell models: up to 2.0 ATA
- + Wheelchair-accessible MC4000 model with roll-in ramp
- + Heat-welded construction (non-toxic, glue-free)
- + CE + ISO 13485 + ISO 9001 + SGS certified
- + Ships to 126+ countries
- + Lifetime warranty claimed by manufacturer
The trade-offs.
- + **Widest product range of any manufacturer** — ultra-budget soft-shell ($2,500) through wheelchair-accessible and clinical hard-shell 2.0 ATA
- + Strong value for money at every tier
- + Direct manufacturer relationship (vs retailer positioning)
- + 2009-founded with established Chinese manufacturing infrastructure
- − **Not FDA-cleared** for US market — China-based manufacturer with international distribution
- − Quality variance documented across product tiers
- − Limited US support / warranty service
- − Brand awareness lower than US-domestic alternatives
- − Shipping logistics + customs add cost / delivery friction
Home wellness users, spas, clinics, wheelchair-accessible needs, international markets
The long read.
§ Hands-on instrument testing pending. Based on published specifications and third-party data.
Overview
Macy-Pan is the China-manufactured widest-product-range hyperbaric chamber specialist — founded 2009 in Shanghai, with structural positioning built on largest catalog from ultra-budget soft-shell ($2,500) through wheelchair-accessible and clinical hard-shell 2.0 ATA units at meaningfully lower pricing than US-domestic FDA-cleared alternatives. Direct manufacturer relationship eliminates retailer markup. For cost-priority international buyers wanting access to multiple chamber types from single manufacturer, Macy-Pan is structurally appropriate.
The structural editorial caveats are real: not FDA-cleared for US market (vs Newtowne K051759, Summit to Sea K072757), quality variance across product tiers documented in user reports, limited US support / warranty service, lower brand awareness, and shipping logistics + customs friction. For users matched to cost-priority China-direct positioning willing to absorb regulatory + support trade-offs, Macy-Pan is appropriate. For US-domestic FDA-cleared positioning, alternatives are structurally better.
When Macy-Pan Makes Sense
Strong fit: Cost-priority buyers (US-domestic alternatives are 2× more expensive); international buyers in non-US markets; users wanting multiple chamber types from single manufacturer; hard-shell 2.0 ATA at reduced cost.
Weaker fit: FDA-cleared positioning preference (Newtowne, Summit to Sea); US support priority; soft-shell residential 1.3 ATA (Newtowne is $1,995 cheaper at FDA-cleared tier).
3-Year Cost of Ownership
| Use case | Cost |
|---|---|
| Macy-Pan soft-shell | ~$2,500-3,500 |
| Macy-Pan mid-tier | ~$3,500-5,000 |
Compare: Newtowne ($4,495 FDA-cleared), Summit to Sea ($3,800-6,500 FDA-cleared), OxyRevo ($2,500-5,500 China-direct alternative), OxyHealth (~$5,500+ FDA-cleared).
Verdict: Conditional
Macy-Pan earns a conditional verdict on the strength of its widest product range from any manufacturer (soft-shell to hard-shell 2.0 ATA), strong value-for-money at every tier, direct manufacturer relationship eliminating retailer markup, and 2009-founded established Chinese manufacturing — balanced against not-FDA-cleared for US market, quality variance across product tiers, limited US support / warranty, lower brand awareness, and shipping / customs friction.
For cost-priority international buyers wanting widest-range single-manufacturer access, Macy-Pan is structurally appropriate. For US-domestic FDA-cleared positioning or US support priority, alternatives are structurally better matched.
Changelog
- 2026-05-07: Initial review published based on Macy-Pan published specifications, China manufacturing positioning, widest-range product line documentation, and aggregated user-report data.
What we'll measure on the bench.
- Protocol
- Pressure gauge + dB-A meter + stopwatch
- Primary metric
- Max ATA pressure + pressurization time
- Pass threshold
- ±0.05 ATA of vendor claim · <70 dB-A
- Session shape
- 3 pressurization cycles + ambient dB at 6 ft
§ Bench session pending. Measured values will replace this panel as the protocol completes — see Plate VI · Methodology for the full testing rulebook.